Where is the live CopyMark page for USPTO serial 85360467?

The live record is at https://getcopymark.com/trademark/85360467. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns DRUG DELIVERY ENGINE?

According to the public USPTO record for serial number 85360467, the listed owner(s) include: INTELLIPHARMACEUTICS CORP..

What is USPTO serial number 85360467?

Serial number 85360467 is the USPTO application identifier for the mark DRUG DELIVERY ENGINE. It is used to track examination, publication, and registration of this trademark.

What is the current status of DRUG DELIVERY ENGINE?

DRUG DELIVERY ENGINE (85360467) currently shows USPTO status code 603 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover DRUG DELIVERY ENGINE?

The public record lists International Classes: 005, 042. Each class corresponds to categories of goods or services identified in the application or registration.

4.9/5

USPTO serial 85360467

DRUG DELIVERY ENGINE

Reviewed by CopyMark Law Group

Status 603

Filing date: Jun 30, 2011
Status date: Sep 22, 2015
Registration date: —
Examiner: CHARLON, BARNEY
Law office: TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DRUG DELIVERY ENGINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

INTELLIPHARMACEUTICS CORP.
Toronto, CA
Other trademarks owned by INTELLIPHARMACEUTICS CORP.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erik M. Pelton

ERIK M PELTON ERIK M PELTON & ASSOCIATES PLLCPO BOX 100637ARLINGTON, VA 22210UNITED STATES

Goods and services

Class	Description	Status	First use
005	Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of a wide variety of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis	ACTIVE	—
042	Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies in the field of controlled, timed release and/or targeted release pharmaceutical preparations	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Sep 22, 2015	MAB3	ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL	—
Sep 22, 2015	ABN3	ABANDONMENT - AFTER EX PARTE APPEAL	—
Sep 22, 2015	EXPT	EXPARTE APPEAL TERMINATED	—
May 29, 2015	EXPA	EX PARTE APPEAL-REFUSAL AFFIRMED	—
Jan 30, 2015	RBFT	REPLY BRIEF FILED - CHECK TTAB FILES	—
Jan 30, 2015	RBFT	REPLY BRIEF FILED - CHECK TTAB FILES	—
Jan 9, 2015	GNSN	NOTIFICATION OF EXAMINERS STATEMENT E-MAILED	—
Jan 9, 2015	GNES	EXAMINERS STATEMENT E-MAILED	—
Jan 9, 2015	CNES	EXAMINERS STATEMENT - COMPLETED	—
Nov 13, 2014	JURT	JURISDICTION RESTORED TO EXAMINING ATTORNEY	—
Sep 10, 2014	EXPI	EX PARTE APPEAL-INSTITUTED	—
Sep 10, 2014	EXAF	EXPARTE APPEAL RECEIVED AT TTAB	—
Mar 15, 2014	GNFN	NOTIFICATION OF FINAL REFUSAL EMAILED	—
Mar 15, 2014	GNFR	FINAL REFUSAL E-MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 15, 2014	CNFR	FINAL REFUSAL WRITTEN	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 19, 2014	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Feb 19, 2014	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Feb 13, 2014	ALIE	ASSIGNED TO LIE	—
Feb 12, 2014	ERSI	TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED	—
Jan 14, 2014	GNS2	NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED	—
Jan 14, 2014	GNSI	INQUIRY TO SUSPENSION E-MAILED	—
Jan 14, 2014	CNSI	SUSPENSION INQUIRY WRITTEN	—
Jan 2, 2014	RCCK	SUSPENSION CHECKED - TO ATTORNEY FOR ACTION	—
Jun 26, 2013	GNS3	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	—
Jun 26, 2013	GNSL	LETTER OF SUSPENSION E-MAILED	—
Jun 26, 2013	CNSL	SUSPENSION LETTER WRITTEN	—
Jun 5, 2013	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jun 5, 2013	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
May 29, 2013	ERSI	TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED	—
Dec 9, 2012	GNS2	NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED	—
Dec 9, 2012	GNSI	INQUIRY TO SUSPENSION E-MAILED	—
Dec 9, 2012	CNSI	SUSPENSION INQUIRY WRITTEN	—
Dec 6, 2012	RCCK	SUSPENSION CHECKED - TO ATTORNEY FOR ACTION	—
Jun 3, 2012	GNS3	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	—
Jun 3, 2012	GNSL	LETTER OF SUSPENSION E-MAILED	—
Jun 3, 2012	CNSL	SUSPENSION LETTER WRITTEN	—
May 11, 2012	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
May 11, 2012	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Apr 30, 2012	ALIE	ASSIGNED TO LIE	—
Apr 23, 2012	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2011	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2011	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 25, 2011	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 18, 2011	DOCK	ASSIGNED TO EXAMINER	—
Jul 7, 2011	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jul 4, 2011	NWAP	NEW APPLICATION ENTERED	—